Vitrakvi (Larotrectinib)

Vitrakvi

Larotrectinib

Capsules: 25 mg, 100 mg 

Bayer Pharmaceuticals

Details:

Medical uses:

Vitrakvi is a kinase inhibitor used for treating adult and pediatric patients with solid tumors that:

  • Have an NTRK gene fusion without any known resistance mutations,
  • Are metastatic or where surgical removal would cause significant morbidity,
  • Have no satisfactory alternative treatments or have progressed after previous treatments.

Recommended Dosage:

  • For adults and pediatric patients with a body surface area (BSA) of at least 1.0 m²: 100 mg orally twice daily.
  • For pediatric patients with a BSA less than 1.0 m²: 100 mg/m² orally twice daily.

Take Vitrakvi capsules with or without food, swallowing them whole with water. Do not chew or crush the capsules. If a dose is missed, do not take it within six hours of the next scheduled dose. If vomiting occurs after taking a dose, take the next dose at the regular time.

Warnings & Precautions:

Patients taking Larotrectinib may experience central nervous system (CNS) side effects such as mood disorders, dizziness, cognitive impairment, and sleep disturbances. It is advised that patients avoid driving or operating machinery if they experience these neurologic side effects.

For patients showing signs or symptoms of fractures (e.g., changes in mobility, deformity, pain), prompt assessment is necessary. Currently, there is no data on Larotrectinib’s impact on the healing of existing fractures or the risk of future fractures.

In patients receiving Vitrakvi at a dose of 100 mg, there may be an increase in AST and ALT levels of any grade. Liver function tests, including AST and ALT, should be monitored every 14 days during the first month of therapy and then monthly thereafter.

Due to its mechanism of action, Larotrectinib can cause fetal harm if administered to pregnant women. Women of reproductive age should use effective contraception during treatment and for seven days after the last dose of Vitrakvi.

 

Documentation & Availability :

Documents  required to import VITRAKVI  to India? 

VITRAKVI (larotrectinib) capsules can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:

  1. 2 ID proofs along with PAN card details along with attested scanned copies
  2. Valid doctor prescription scanned copy
  3. Doctor’s MCI number
  4. Doctor’s mobile number
  5. Patients diagnostic reports

 

How is the order confirmed? 

The order will be confirmed only after the receipt of:

  1. The above-mentioned documents and drug availability.
  2. Import permit if applicable.

 

Sourcing & Delivery:

The Rx4U team has extensive experience in sourcing  VITRAKVI (Cancer Treatment Medicines) from around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.

 

 FAQ:

What is the Generic Name for Vitrakvi®?

The generic name for Vitrakvi® is Larotrectinib.

Who manufactures Vitrakvi®?

Vitrakvi® is produced by Bayer Pharmaceuticals.

Is Vitrakvi® FDA approved?

Yes, Vitrakvi® received FDA approval on November 26, 2018.

Where can I find the best price for Vitrakvi® in India?

For the best price on Vitrakvi 100 mg in India, contact the Rx4u team.

What are the available dosages and forms of Vitrakvi®?

Vitrakvi® is available in capsule form, with dosages of 25 mg and 100 mg for oral use.

What are the common side effects of Vitrakvi®?

Common side effects include constipation, diarrhea, dizziness, low calcium levels, vomiting, nausea, fever, stomach pain, cough, fatigue, muscle and bone pain, and low red and white blood cell counts.

How much does Vitrakvi® cost in India?

The price of Vitrakvi in India can vary due to international factors. To purchase this kinase inhibitor legally, you can reach out to Rx4u team.

What are the storage conditions for Vitrakvi®?

Store Vitrakvi® capsules at 20-25°C (68-77°F). Temperature excursions between 15°C and 30°C (59°F to 86°F) are allowed.

Is it safe to buy Vitrakvi® online in India?

Yes, you can safely purchase Vitrakvi® online in India through https://rx4u.in/.

 

*Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.